In prostate cancer cells, SNHG1 competitively inhibits miR-377-3p expression, leading to AKT2 hyperactivation, which facilitates proliferation and suppresses apoptosis in prostate cancer cells 34. Here, AKT2 is linked to prostate carcinoma.